Emily Adams
Emily Adams | |
|---|---|
| Alma mater | Bristol University |
| Known for | Molecular diagnostics |
| Scientific career | |
| Institutions | Liverpool School of Tropical Medicine |
| Website | www |
Emily Adams is a Reader in Diagnostics for Infectious Disease at Liverpool School of Tropical Medicine.[1] She is diagnostic lead for the Centre for Drugs and Diagnostics developing with industry diagnostics for various diseases. She is also the Director for Epidemics and Neglected Tropical Disease at Global Access Diagnostics (formerly Mologic), a not-for-profit diagnostics company in the UK.
Life[edit]
She was World Health Organization TDR (Special Programme on Tropical Diseases Research) consultant in their RDT evaluation for Leishmaniasis program whilst working at the Koninklijk Instituut voor de Tropen.[2][3]
References[edit]
- ^ Tobin, Olivia (22 March 2020). "Liverpool researchers working on "gamechanger" coronavirus test". liverpoolecho.
- ^ World Health Organisation (2011). Visceral leishmaniasis rapid diagnostic test performance (PDF). ISBN 9789241502238. Retrieved 30 March 2020.
- ^ Cunningham, Jane; Hasker, Epco; Das, Pradeep; El Safi, Sayda; Goto, Hiro; Mondal, Dinesh; Mbuchi, Margaret; Mukhtar, Maowia; Rabello, Ana; Rijal, Suman; Sundar, Shyam; Wasunna, Monique; Adams, Emily; Menten, Joris; Peeling, Rosanna; Boelaert, Marleen (15 November 2012). "A Global Comparative Evaluation of Commercial Immunochromatographic Rapid Diagnostic Tests for Visceral Leishmaniasis". Clinical Infectious Diseases. 55 (10): 1312–1319. doi:10.1093/cid/cis716. PMC 3478143. PMID 22942208.
External links[edit]
| International | |
|---|---|
| National | |
| Academics | |
 | This article about a British scientist is a stub. You can help Wikipedia by expanding it. |